GlassScriptPhysician profile
Paul V Tuttle
NPI 1023243805
$3,705.84
in general payments reported to CMS, 2019-2025
19 companies · $1,106 in 2025
The $1,106 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $196 · 2021: $349 · 2022: $580 · 2023: $462 · 2024: $678 · 2025: $1,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,190 · Education: $55.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,189.88 |
| Education | $55.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,935.42 | 2019-2025 | Rinvoq, Skyrizi |
| Amgen INC. | $494.04 | 2019-2025 | Uplizna, Evenity, Avsola |
| Novartis Pharmaceuticals Corporation | $211.52 | 2022-2025 | |
| Horizon Therapeutics Plc | $204.32 | 2021 | |
| Genzyme Corporation | $147.75 | 2025 | |
| Janssen Biotech, INC. | $136.60 | 2022-2025 | Tremfya |
| Lilly USA, LLC | $110.60 | 2023-2025 | Taltz |
| Astrazeneca Pharmaceuticals LP | $93.96 | 2024-2025 | Saphnelo |
| Ucb, INC. | $73.44 | 2023-2025 | Cimzia, Bimzelx |
| Glaxosmithkline, LLC. | $70.38 | 2019-2025 | Benlysta |
| Pfizer INC. | $55.35 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $41.69 | 2024-2025 | Orencia |
| Tg Therapeutics, INC. | $27.91 | 2025 | |
| Genentech USA, INC. | $21.63 | 2024 | Actemra |
| Teva Pharmaceuticals USA, INC. | $20.78 | 2023 | Truxima |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $19.25 | 2023 | |
| Sandoz INC. | $19.07 | 2024 | Hyrimoz |
| US Oncology Corporate, INC. | $16.62 | 2023 | |
| Electronic Waveform Lab, INC. | $5.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Tuttle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.